UBS analyst Joseph Parkhill maintained a Buy rating on Plains All American (PAA – Research Report) on July 8 and set a price target of $17.00. The companys shares closed last Friday at $10.18.

According to TipRanks.com, Parkhill is ranked #4921 out of 7918 analysts.

Currently, the analyst consensus on Plains All American is a Strong Buy with an average price target of $14.25.

See the top stocks recommended by analysts >> Based on Plains All Americans latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $13.69 billion and net profit of $187 million. In comparison, last year the company earned revenue of $8.38 billion and had a net profit of $422 million. Based on the recent corporate insider activity of 21 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of PAA in relation to earlier this year. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. Plains All American Pipeline LP engages in the provision of transportation, storage, terminalling and marketing of crude oil, refined products and other natural gas-related petroleum products. It operates through the following business segments: Transportation, Facilities, and Supply and Logistics. The Transportation segments consist of fee-based activities associated with transporting crude oil and refined products on pipelines, gathering systems, trucks and barges. The Facilities segment includes fee-based activities associated with providing storage, terminalling and throughput services for crude oil, refined products, and natural gas, as well LPG fractionation and isomerization services. The Supply and Logistics segment is engaged in the sale of gathered and bulk-purchased crude oil and natural gas liquids volumes. The company was founded in 1998 and is headquartered in Houston, TX. Read More on PAA:

• UBS Maintains Their Buy Rating on Plains GP Holdings (PAGP)
• UBS Keeps a Buy Rating on Enterprise Products Partners (EPD)
• Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), SAGE Therapeutics (SAGE) and Alector (ALEC)
• Analysts Offer Insights on Utilities Companies: Pioneer Natural (PXD) and Chord Energy (CHRD)
• Analysts Offer Insights on Consumer Goods Companies: Murphy USA (MUSA) and Kontoor Brands (KTB)